Atlas Trials

A Phase IV Study to Assess the Impact of the Change of Antiretroviral Treatment From Dual Therapy to Triple Therapy on Inflammation in Patients With HIV Infection

Clinical trial NCT04076423 · COMPLETED

Trial details

NCT number
NCT04076423
Sponsor
Fundacion SEIMC-GESIDA
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HIV Infections
Start date
2019-10-10
Primary completion
2023-06-15
Enrollment
141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.